Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

SHL Telemedicine Gelecekteki Büyüme

Future kriter kontrolleri 1/6

SHL Telemedicine şirketinin yıllık kazanç ve gelirinin sırasıyla 132.1% ve 19.8% oranında artması bekleniyor.

Anahtar bilgiler

132.1%

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi	20.5%
Gelir büyüme oranı	19.8%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	07 May 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower

Oct 10

Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding

Aug 21

Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher

Jun 04

SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing

Apr 20

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Dec 01

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Oct 28

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Jun 23

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Mar 05

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 12

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

Jan 21

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

Jan 04

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

Dec 01

Kazanç ve Gelir Büyüme Tahminleri

SWX:SHLTN - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2025	75	0	N/A	N/A	1
12/31/2024	62	-4	N/A	N/A	1
6/30/2024	56	-9	-4	1	N/A
3/31/2024	57	-8	-5	0	N/A
12/31/2023	57	-7	-7	-1	N/A
9/30/2023	57	-5	-9	-3	N/A
6/30/2023	57	-2	-12	-5	N/A
3/31/2023	58	-1	-9	-3	N/A
12/31/2022	59	0	-7	0	N/A
9/30/2022	59	-2	-5	1	N/A
6/30/2022	59	-4	-3	3	N/A
3/31/2022	55	-9	-3	1	N/A
12/31/2021	50	-14	-3	0	N/A
9/30/2021	46	-12	-2	1	N/A
6/30/2021	42	-10	0	2	N/A
3/31/2021	41	-5	1	3	N/A
12/31/2020	40	0	3	5	N/A
9/30/2020	40	1	4	6	N/A
6/30/2020	40	2	5	7	N/A
3/31/2020	41	4	7	9	N/A
12/31/2019	42	6	9	11	N/A
9/30/2019	42	6	13	14	N/A
6/30/2019	42	5	16	18	N/A
3/31/2019	45	8	14	15	N/A
12/31/2018	49	10	12	13	N/A
9/30/2018	49	10	5	7	N/A
6/30/2018	48	9	-1	1	N/A
3/31/2018	43	6	N/A	7	N/A
12/31/2017	37	2	N/A	12	N/A
9/30/2017	37	-1	N/A	12	N/A
6/30/2017	36	-5	N/A	12	N/A
3/31/2017	36	-8	N/A	6	N/A
12/31/2016	36	-11	N/A	0	N/A
9/30/2016	36	-15	N/A	-1	N/A
6/30/2016	36	-20	N/A	-1	N/A
3/31/2016	39	-19	N/A	4	N/A
12/31/2015	39	-16	N/A	4	N/A
9/30/2015	40	-8	N/A	4	N/A
6/30/2015	40	1	N/A	5	N/A
3/31/2015	39	2	N/A	-1	N/A
12/31/2014	40	1	N/A	-3	N/A
9/30/2014	39	4	N/A	-3	N/A
6/30/2014	36	3	N/A	-4	N/A
3/31/2014	33	3	N/A	-3	N/A
12/31/2013	30	2	N/A	3	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: SHLTN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: SHLTN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: SHLTN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: SHLTN şirketinin gelirinin (yıllık 19.8% ) Swiss pazarından (yıllık 4.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: SHLTN şirketinin gelirinin (yıllık 19.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: SHLTN 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

SHL Telemedicine Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Forecast to breakeven in 2025

Recent updates

Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower

First half 2024 earnings released: US$0.24 loss per share (vs US$0.14 loss in 1H 2023)

New minor risk - Profitability

Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding

SHL Telemedicine Ltd. Appoints David Arnon as CEO, Effective from August 6, 2024

Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher

SHL Telemedicine Ltd. to Report First Half, 2024 Results on Sep 26, 2024

SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing

Full year 2023 earnings released: US$0.43 loss per share (vs US$0.005 loss in FY 2022)

Forecast to breakeven in 2025

SHL Telemedicine Ltd. Announces Full Results of the Imperial College London Tele-ACS Trial

SHL Telemedicine's SmartHeart Technology Triumphs in US Army Project Convergence - Capstone 4 Experiment

New minor risk - Financial data availability

SHL Telemedicine Ltd. Announces Erez Nachtomy, to Steps Down as CEO in Mid-June 2024

Value Base Ltd Provides Information to Shareholders of SHL Telemedicine

New minor risk - Market cap size

Insufficient new directors

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. to Report Fiscal Year 2023 Results on Apr 17, 2024

SHL Telemedicine Ltd., Annual General Meeting, Feb 08, 2024

Danbar Finance Nominates a Candidate to the Board of SHL Telemedicine

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Shl Telemedicine Ltd. Announces the Initial Results from the Mayo Clinic Help-Mi and the Imperial College London Tele-Acs Trials

First half 2023 earnings released: US$0.14 loss per share (vs US$0.002 profit in 1H 2022)

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Full year 2022 earnings released

SHL Telemedicine Ltd., Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

SHL Telemedicine Ltd. Appoints Kimberly J. Henderson and Joshua H. Atkins to its US Advisory Board

SHL Telemedicine Ltd. Appoints Ehud Barak as Co-Chairman

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

SHL Telemedicine Ltd. to Report Fiscal Year 2021 Results on Apr 14, 2022

SHL Telemedicine Ltd. to Report First Half, 2022 Results on Sep 22, 2022

First half 2021 earnings released: US$0.75 loss per share (vs US$0.01 profit in 1H 2020)

SHL Telemedicine Ltd completed the acquisition of a 70% stake in Mediton Medical Centers Ltd.

SHL Telemedicine Ltd. (SWX:SHLTN) signed an agreement to acquire 70% of the Mediton Group companies for ILS 84 million ($26 million).

Full year 2020 earnings released: EPS US$0.03 (vs US$0.54 in FY 2019)

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

SHL Telemedicine Announces Executive Changes

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

SHL Telemedicine Ltd. Files Pre-Submission with FDA for over the Counter Clearance of SHL’S Smartheart™ Full 12 Lead ECG

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

New 90-day high: CHF10.90

Investor sentiment improved over the past week

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

New 90-day high: CHF8.80

SHL Telemedicine to Launch Doctors’ Virtual Visits with Health Insurance Company BARMER

AI Tool Jointly Develops by Hadassah Medical Center – SHL Telemedicine – Hebrew University

Market bids up stock over the past week

New 90-day high: CHF6.80

Market bids up stock over the past week

Mayo Clinic Collaborates with SHL Telemedicine using SmartHeart™ Technology 12 lead ECG

New 90-day high: CHF5.90

First half earnings released

New 90-day low - CHF5.30

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin